奥卡西平诱发的史蒂文-约翰逊综合征

Q4 Psychology

Archives of Mental Health Pub Date : 2021-07-01 DOI:10.4103/amh.amh_55_20

G. Godasi, R. Donthu, Raja Godasi

{"title":"奥卡西平诱发的史蒂文-约翰逊综合征","authors":"G. Godasi, R. Donthu, Raja Godasi","doi":"10.4103/amh.amh_55_20","DOIUrl":null,"url":null,"abstract":"Carbamazepine has been well documented to be associated with Steven–Johnson Syndrome (SJS). The newer anti-epileptic oxcarbazepine has not been demonstrated to be associated with this rare side effect except in some case reports. We present a case of SJS caused due to use of oxcarbazepine in a patient of schizophrenia.","PeriodicalId":36181,"journal":{"name":"Archives of Mental Health","volume":"22 1","pages":"171 - 173"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Oxcarbazepine-induced Steven–Johnson syndrome\",\"authors\":\"G. Godasi, R. Donthu, Raja Godasi\",\"doi\":\"10.4103/amh.amh_55_20\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Carbamazepine has been well documented to be associated with Steven–Johnson Syndrome (SJS). The newer anti-epileptic oxcarbazepine has not been demonstrated to be associated with this rare side effect except in some case reports. We present a case of SJS caused due to use of oxcarbazepine in a patient of schizophrenia.\",\"PeriodicalId\":36181,\"journal\":{\"name\":\"Archives of Mental Health\",\"volume\":\"22 1\",\"pages\":\"171 - 173\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Mental Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/amh.amh_55_20\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Psychology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Mental Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/amh.amh_55_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Psychology","Score":null,"Total":0}

引用次数: 0

摘要

卡马西平与史蒂文-约翰逊综合征(SJS)有关。新的抗癫痫药物奥卡西平除了一些病例报道外，尚未被证明与这种罕见的副作用有关。我们提出一个病例的SJS由于使用奥卡西平引起的精神分裂症患者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Oxcarbazepine-induced Steven–Johnson syndrome

Carbamazepine has been well documented to be associated with Steven–Johnson Syndrome (SJS). The newer anti-epileptic oxcarbazepine has not been demonstrated to be associated with this rare side effect except in some case reports. We present a case of SJS caused due to use of oxcarbazepine in a patient of schizophrenia.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Archives of Mental Health Psychology-Clinical Psychology

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

20 weeks